Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ledda

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Angiology|October 23, 1998
Shock waves in vascular diseases: an in-vitro studyG Belcaro, A N Nicolaides, E H Marlinghaus, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 9, 2006
Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenolG Belcaro, M R Cesarone, B M Errichi, et al.
Minerva Cardioangiologica|July 15, 2009
[NPT (near patient test) in the pharmacy: document and practice guidelines 2008]S Stuard, M R Cesarone, G Belcaro, et al.
Minerva Cardioangiologica|August 4, 2012
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]R Luzzi, G Belcaro, E Ippolito, et al.
Angiology|October 7, 2006
Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled studyM R Cesarone, G Belcaro, P Rohdewald, et al.
Panminerva Medica|November 24, 2011
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot studyG Appendino, G Belcaro, U Cornelli, et al.
Redox Report : Communications in Free Radical Research|November 20, 2008
Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with PycnogenolG Belcaro, M R Cesarone, S Errichi, et al.
Phytotherapy Research : PTR|April 4, 2008
Treatment of osteoarthritis with Pycnogenol. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of signs, symptoms, physical performance and vascular aspectsG Belcaro, M R Cesarone, S Errichi, et al.
Angiology|May 5, 2007
Topical heparin: new observationsM R Cesarone, G Belcaro, S Errichi, et al.
Angiology|November 20, 1998
Treatment of severe intermittent claudication with PGE1--a short-term vs a long-term infusion plan--a 20 week, European randomized trial--analysis of efficacy and costsG Belcaro, G Laurora, A N Nicolaides, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Angiology|October 23, 1998
Shock waves in vascular diseases: an in-vitro studyG Belcaro, A N Nicolaides, E H Marlinghaus, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 9, 2006
Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenolG Belcaro, M R Cesarone, B M Errichi, et al.
Minerva Cardioangiologica|July 15, 2009
[NPT (near patient test) in the pharmacy: document and practice guidelines 2008]S Stuard, M R Cesarone, G Belcaro, et al.
Minerva Cardioangiologica|August 4, 2012
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]R Luzzi, G Belcaro, E Ippolito, et al.
Angiology|October 7, 2006
Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled studyM R Cesarone, G Belcaro, P Rohdewald, et al.
Panminerva Medica|November 24, 2011
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot studyG Appendino, G Belcaro, U Cornelli, et al.
Redox Report : Communications in Free Radical Research|November 20, 2008
Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with PycnogenolG Belcaro, M R Cesarone, S Errichi, et al.
Phytotherapy Research : PTR|April 4, 2008
Treatment of osteoarthritis with Pycnogenol. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of signs, symptoms, physical performance and vascular aspectsG Belcaro, M R Cesarone, S Errichi, et al.
Angiology|May 5, 2007
Topical heparin: new observationsM R Cesarone, G Belcaro, S Errichi, et al.
Angiology|November 20, 1998
Treatment of severe intermittent claudication with PGE1--a short-term vs a long-term infusion plan--a 20 week, European randomized trial--analysis of efficacy and costsG Belcaro, G Laurora, A N Nicolaides, et al.
Pageof 12